☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Jacobio
Jacobio Entered into a Clinical Collaboration with Merck to Evaluate JAB-BX102 + Keytruda (pembrolizumab) for Solid Tumors
March 22, 2023
Jacobio Reports the Completion of First Patient Dosing of JAB-21822 + Cetuximab in Clinical Trials for the Treatment of Colorectal...
February 24, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.